1
|
Grubaugh ND, Torres-Hernández D, Murillo-Ortiz MA, Dávalos DM, Lopez P, Hurtado IC, Breban MI, Bourgikos E, Hill V, López-Medina E. Dengue Outbreak Caused by Multiple Virus Serotypes and Lineages, Colombia, 2023-2024. Emerg Infect Dis 2024; 30:2391-2395. [PMID: 39378873 PMCID: PMC11521178 DOI: 10.3201/eid3011.241031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/10/2024] Open
Abstract
Dengue cases rose to record levels during 2023-2024. We investigated dengue in Valle del Cauca, Colombia, to determine if specific virus serotypes or lineages caused its large outbreak. We detected all 4 serotypes and multiple lineages, suggesting that factors such as climatic conditions were likely responsible for increased dengue in Colombia.
Collapse
|
2
|
Martínez D, Gómez M, Hernández C, Campo-Palacio S, González-Robayo M, Montilla M, Pavas-Escobar N, Tovar-Acero C, Geovo-Arias L, Valencia-Urrutia E, Córdoba-Renteria N, Carrillo-Hernandez MY, Ruiz-Saenz J, Martinez-Gutierrez M, Paniz-Mondolfi A, Patiño LH, Muñoz M, Ramírez JD. Cryptic transmission and novel introduction of Dengue 1 and 2 genotypes in Colombia. Virus Evol 2024; 10:veae068. [PMID: 39347444 PMCID: PMC11429525 DOI: 10.1093/ve/veae068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Revised: 07/03/2024] [Accepted: 08/27/2024] [Indexed: 10/01/2024] Open
Abstract
Dengue fever remains as a public health challenge in Colombia, standing as the most prevalent infectious disease in the country. The cyclic nature of dengue epidemics, occurring approximately every 3 years, is intricately linked to meteorological events like El Niño Southern Oscillation (ENSO). Therefore, the Colombian system faces challenges in genomic surveillance. This study aimed to evaluate local dengue virus (DENV) transmission and genetic diversity in four Colombian departments with heterogeneous incidence patterns (department is first-level territorial units in Colombia). For this study, we processed 266 serum samples to identify DENV. Subsequently, we obtained 118 genome sequences by sequencing DENV genomes from serum samples of 134 patients infected with DENV-1 and DENV-2 serotypes. The predominant serotype was DENV-2 (108/143), with the Asian-American (AA) genotype (91/118) being the most prevalent one. Phylogenetic analysis revealed concurrent circulation of two lineages of both DENV-2 AA and DENV-1 V, suggesting ongoing genetic exchange with sequences from Venezuela and Cuba. The continuous migration of Venezuelan citizens into Colombia can contribute to this exchange, emphasizing the need for strengthened prevention measures in border areas. Notably, the time to most recent common ancestor analysis identified cryptic transmission of DENV-2 AA since approximately 2015, leading to the recent epidemic. This challenges the notion that major outbreaks are solely triggered by recent virus introductions, emphasizing the importance of active genomic surveillance. The study also highlighted the contrasting selection pressures on DENV-1 V and DENV-2 AA, with the latter experiencing positive selection, possibly influencing its transmissibility. The presence of a cosmopolitan genotype in Colombia, previously reported in Brazil and Peru, raises concerns about transmission routes, emphasizing the necessity for thorough DENV evolution studies. Despite limitations, the study underscores genomic epidemiology's crucial role in early detection and comprehension of DENV genotypes, recommending the use of advanced sequencing techniques as an early warning system to help prevent and control dengue outbreaks in Colombia and worldwide.
Collapse
Affiliation(s)
- David Martínez
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
| | - Marcela Gómez
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
- Grupo de Investigación en Ciencias Básicas (NÚCLEO) Facultad de Ciencias e Ingeniería, Universidad de Boyacá, Tunja, Colombia
| | - Carolina Hernández
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
- Centro de Tecnología en Salud (CETESA), Innovaseq SAS, Bogotá, Colombia
- Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Sandra Campo-Palacio
- Laboratorio de Salud Pública, Secretaría de Salud Departamental Meta, Villavicencio, Colombia
| | - Marina González-Robayo
- Laboratorio de Salud Pública, Secretaría de Salud Departamental Meta, Villavicencio, Colombia
| | - Marcela Montilla
- Laboratorio de Salud Pública, Secretaría de Salud Departamental Meta, Villavicencio, Colombia
- Universidad Cooperativa de Colombia, Villavicencio, Colombia
| | - Norma Pavas-Escobar
- Laboratorio de Salud Pública, Secretaría de Salud Departamental Meta, Villavicencio, Colombia
- Universidad Cooperativa de Colombia, Villavicencio, Colombia
| | - Catalina Tovar-Acero
- Grupo de Enfermedades Tropicales y Resistencia Bacteriana, Universidad del Sinú, Montería, Córdoba, Colombia
| | - Lillys Geovo-Arias
- Secretaria de Salud departamental Chocó-Laboratorio de Salud Pública, Chocó, Colombia
| | | | | | - Marlen Y Carrillo-Hernandez
- Grupo de Investigación en Ciencias Animales-GRICA, Universidad Cooperativa de Colombia, Bucaramanga, Colombia
- Programa de Estudio y Control de Enfermedades Tropicales-PECET, Universidad de Antioquia, Medellín, Colombia
| | - Julian Ruiz-Saenz
- Grupo de Investigación en Ciencias Animales-GRICA, Universidad Cooperativa de Colombia, Bucaramanga, Colombia
| | - Marlen Martinez-Gutierrez
- Grupo de Investigación en Ciencias Animales-GRICA, Universidad Cooperativa de Colombia, Bucaramanga, Colombia
- Programa de Estudio y Control de Enfermedades Tropicales-PECET, Universidad de Antioquia, Medellín, Colombia
| | - Alberto Paniz-Mondolfi
- Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Luz H Patiño
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
| | - Marina Muñoz
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
- Molecular Epidemiology Laboratory, Instituto de Biotecnología-UN (IBUN), Universidad Nacional de Colombia, Bogotá, Colombia
| | - Juan David Ramírez
- Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia
- Molecular Microbiology Laboratory, Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| |
Collapse
|
3
|
Grubaugh ND, Torres-Hernández D, Murillo-Ortiz MA, Dávalos DM, Lopez P, Hurtado IC, Breban MI, Bourgikos E, Hill V, López-Medina E. 2023-24 dengue outbreak in Valle del Cauca, Colombia caused by multiple virus serotypes and lineages. MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2024:2024.07.16.24310413. [PMID: 39072046 PMCID: PMC11275674 DOI: 10.1101/2024.07.16.24310413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/30/2024]
Abstract
Global dengue cases rapidly rose to record levels in 2023-24. We investigated this trend in Valle del Cauca, Colombia to determine if specific dengue virus serotypes or lineages were responsible for the large outbreak. We detected all four serotypes and multiple lineages, suggesting that other factors, such as climatic conditions, are likely responsible.
Collapse
Affiliation(s)
- Nathan D. Grubaugh
- Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA
- Public Health Modeling Unit, Yale School of Public Health, New Haven, Connecticut, USA
- Yale Institute for Global Health, Yale University, New Haven, Connecticut, USA
- Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium
| | | | - Mónica A. Murillo-Ortiz
- School of Bacteriology and Clinical Laboratory, Universidad del Valle, Cali, Colombia
- Hospital Universitario del Valle “Evaristo García” E.S.E, Cali, Colombia
| | - Diana M. Dávalos
- Centro de Estudios en Infectología Pediátrica CEIP, Cali, Colombia
| | - Pio Lopez
- Centro de Estudios en Infectología Pediátrica CEIP, Cali, Colombia
| | - Isabel C. Hurtado
- Department of Pediatrics, Universidad del Valle, Cali, Colombia
- Hospital Universitario del Valle “Evaristo García” E.S.E, Cali, Colombia
- Valle del Cauca State Health Department, Cali, Colombia
| | - Mallery I. Breban
- Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA
| | - Ellie Bourgikos
- Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA
| | - Verity Hill
- Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA
| | - Eduardo López-Medina
- Department of Pediatrics, Universidad del Valle, Cali, Colombia
- Centro de Estudios en Infectología Pediátrica CEIP, Cali, Colombia
- Clínica Imbanaco, Grupo Quironsalud, Cali, Colombia
| |
Collapse
|
4
|
Keirsebelik MSG, David MR, Pavan MG, Couto-Lima D, Palomino M, Rahman RU, Hoffmann AA, Bahia AC, Caljon G, Maciel-de-Freitas R. Dengue Virus Serotype 1 Effects on Mosquito Survival Differ among Geographically Distinct Aedes aegypti Populations. INSECTS 2024; 15:393. [PMID: 38921108 PMCID: PMC11203567 DOI: 10.3390/insects15060393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/25/2024] [Revised: 05/17/2024] [Accepted: 05/21/2024] [Indexed: 06/27/2024]
Abstract
The mosquito Aedes aegypti is distributed worldwide and is recognized as the primary vector for dengue in numerous countries. To investigate whether the fitness cost of a single DENV-1 isolate varies among populations, we selected four Ae. aegypti populations from distinct localities: Australia (AUS), Brazil (BRA), Pakistan (PAK), and Peru (PER). Utilizing simple methodologies, we concurrently assessed survival rates and fecundity. Overall, DENV-1 infection led to a significant decrease in mosquito survival rates, with the exception of the PER population. Furthermore, infected Ae. aegypti from PAK, the population with the lowest infection rate among those tested, exhibited a noteworthy reduction in egg laying. These findings collectively suggest that local mosquito-virus adaptations may influence dengue transmission in endemic settings.
Collapse
Affiliation(s)
- Milan S. G. Keirsebelik
- Laboratório de Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil; (M.S.G.K.); (M.R.D.); (M.G.P.); (D.C.-L.)
- Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, 1, 2610 Wilrijk-Antwerp, Belgium;
| | - Mariana R. David
- Laboratório de Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil; (M.S.G.K.); (M.R.D.); (M.G.P.); (D.C.-L.)
| | - Márcio Galvão Pavan
- Laboratório de Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil; (M.S.G.K.); (M.R.D.); (M.G.P.); (D.C.-L.)
| | - Dinair Couto-Lima
- Laboratório de Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil; (M.S.G.K.); (M.R.D.); (M.G.P.); (D.C.-L.)
| | - Miriam Palomino
- Laboratorio de Referência Nacional de Entomologia, Centro Nacional de Salud Pública, Instituto Nacional de Salud, Lima 15072, Peru;
| | - Rafi Ur Rahman
- Department of Biosciences, COMSATS University, Islamabad 45550, Pakistan;
| | - Ary A. Hoffmann
- Pest and Environmental Adaptation Research Group, Bio21 Institute, School of BioSciences, The University of Melbourne, 3052 Melbourne, Australia;
| | - Ana C. Bahia
- Laboratório de Bioquímica de Insetos e Parasitos, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21040-900, Brazil;
| | - Guy Caljon
- Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, 1, 2610 Wilrijk-Antwerp, Belgium;
| | - Rafael Maciel-de-Freitas
- Laboratório de Transmissores de Hematozoários, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro 21040-900, Brazil; (M.S.G.K.); (M.R.D.); (M.G.P.); (D.C.-L.)
- Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany
| |
Collapse
|
5
|
Garcia--Van Smévoorde M, Piorkowski G, Emboulé L, Dos Santos G, Loraux C, Guyomard-Rabenirina S, Joannes MO, Fagour L, Najioullah F, Cabié A, de Lamballerie X, Vega-Rúa A, Césaire R, Calvez E. Phylogenetic Investigations of Dengue 2019-2021 Outbreak in Guadeloupe and Martinique Caribbean Islands. Pathogens 2023; 12:1182. [PMID: 37764990 PMCID: PMC10534936 DOI: 10.3390/pathogens12091182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2023] [Revised: 09/14/2023] [Accepted: 09/15/2023] [Indexed: 09/29/2023] Open
Abstract
Dengue fever has been a public health problem in the Caribbean region since 1981, when it first reappeared in Cuba. In 1989, it was reported in Martinique and Guadeloupe (two French islands 200 km apart); since then, DENV has caused several epidemics locally. In 2019-2021, DENV-1, DENV-2, and DENV-3 were detected. Serotype distribution was differentiated, with DENV-2 and DENV-3 predominating in Guadeloupe and Martinique, respectively. Complete genome sequencing was carried out on 32 specimens, and phylogenic analysis identified the circulation of genotype V for DENV-1, cosmopolitan genotype for DENV-2, and genotype III for DENV-3. However, two distinct circulating groups were identified for DENV-1 and DENV-3, suggesting independent introductions. Overall, despite the context of the COVID-19 pandemic and the associated travel restrictions, these results confirm the active circulation of DENV and specific epidemiological features on each of the two islands. Such differences may be linked to the founder effect of the various introduction events, and to local factors such as the population immunity and the transmission capacity of the vectors. Further genomic and epidemiological characterization of DENV strains remains essential to understand how dengue spreads in each specific geographical context and to prevent future epidemics.
Collapse
Affiliation(s)
- Margot Garcia--Van Smévoorde
- Vector Control Research Laboratory, Transmission Reservoir and Pathogens Diversity Unit, Institut Pasteur de la Guadeloupe, Les Abymes 97139, Guadeloupe;
| | - Géraldine Piorkowski
- Unité des Virus Emergents (UVE), Aix-Marseille Univ-IRD 190-Inserm 1207, 13005 Marseille, France; (G.P.); (X.d.L.)
- National Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm), 13005 Marseille, France
- French Armed Forces Biomedical Research Institute (IRBA), 91220 Brétigny-sur-Orge, France
| | - Loic Emboulé
- Molecular Genetics and Inherited Red Blood Cell Diseases Laboratory, University Hospitals of Guadeloupe, Pointe-à-Pitre 97159, Guadeloupe;
| | - Georges Dos Santos
- Department of Virology, University Hospitals of Martinique, Fort-de-France, 97200 Martinique, France; (G.D.S.); (L.F.)
- Pathogenesis and Controle of Chronic and Emerging Infections, French National Blood Service (EFS), National Institute of Health and Medical Research (Inserm), University of Montpellier, 34000 Montpellier, France; (A.C.); (R.C.)
- University of Antilles, Pointe-à-Pitre 97110, Guadeloupe
| | - Cécile Loraux
- Department of Virology, University Hospitals of Guadeloupe, Pointe-à-Pitre 97159, Guadeloupe;
| | - Stéphanie Guyomard-Rabenirina
- Microbial Ecosystems Interaction Laboratory, Transmission Reservoir and Pathogens Diversity Unit, Institut Pasteur de la Guadeloupe, Les Abymes 97139, Guadeloupe;
| | - Marie-Odile Joannes
- Department of Hematology Immunology Histocompatibility, University Hospitals of Guadeloupe, Pointe-à-Pitre 97159, Guadeloupe;
| | - Laurence Fagour
- Department of Virology, University Hospitals of Martinique, Fort-de-France, 97200 Martinique, France; (G.D.S.); (L.F.)
| | - Fatiha Najioullah
- Department of Clinical Research and Innovation, University Hospitals of Martinique, Fort-de-France, 97200 Martinique, France;
| | - André Cabié
- Pathogenesis and Controle of Chronic and Emerging Infections, French National Blood Service (EFS), National Institute of Health and Medical Research (Inserm), University of Montpellier, 34000 Montpellier, France; (A.C.); (R.C.)
- University of Antilles, Pointe-à-Pitre 97110, Guadeloupe
- Department of Infectious and Tropical Diseases, University Hospitals of Martinique, Fort-de-France, 97200 Martinique, France
| | - Xavier de Lamballerie
- Unité des Virus Emergents (UVE), Aix-Marseille Univ-IRD 190-Inserm 1207, 13005 Marseille, France; (G.P.); (X.d.L.)
- National Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm), 13005 Marseille, France
| | - Anubis Vega-Rúa
- Vector Control Research Laboratory, Transmission Reservoir and Pathogens Diversity Unit, Institut Pasteur de la Guadeloupe, Les Abymes 97139, Guadeloupe;
| | - Raymond Césaire
- Pathogenesis and Controle of Chronic and Emerging Infections, French National Blood Service (EFS), National Institute of Health and Medical Research (Inserm), University of Montpellier, 34000 Montpellier, France; (A.C.); (R.C.)
- University of Antilles, Pointe-à-Pitre 97110, Guadeloupe
- Department of Virology, University Hospitals of Guadeloupe, Pointe-à-Pitre 97159, Guadeloupe;
| | - Elodie Calvez
- Vector Control Research Laboratory, Transmission Reservoir and Pathogens Diversity Unit, Institut Pasteur de la Guadeloupe, Les Abymes 97139, Guadeloupe;
| |
Collapse
|
6
|
Márquez S, Lee G, Gutiérrez B, Bennett S, Coloma J, Eisenberg JNS, Trueba G. Phylogenetic Analysis of Transmission Dynamics of Dengue in Large and Small Population Centers, Northern Ecuador. Emerg Infect Dis 2023; 29:888-897. [PMID: 37080979 PMCID: PMC10124659 DOI: 10.3201/eid2905.221226] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/22/2023] Open
Abstract
Although dengue is typically considered an urban disease, rural communities are also at high risk. To clarify dynamics of dengue virus (DENV) transmission in settings with characteristics generally considered rural (e.g., lower population density, remoteness), we conducted a phylogenetic analysis in 6 communities in northwestern Ecuador. DENV RNA was detected by PCR in 121/488 serum samples collected from febrile case-patients during 2019-2021. Phylogenetic analysis of 27 samples from Ecuador and other countries in South America confirmed that DENV-1 circulated during May 2019-March 2020 and DENV-2 circulated during December 2020-July 2021. Combining locality and isolation dates, we found strong evidence that DENV entered Ecuador through the northern province of Esmeraldas. Phylogenetic patterns suggest that, within this province, communities with larger populations and commercial centers were more often the source of DENV but that smaller, remote communities also play a role in regional transmission dynamics.
Collapse
|
7
|
The Colombian Zika Virus Isolate (COL345Si) Replicates in Prostate Adenocarcinoma Cells and Modulates the Antiviral Response. Microorganisms 2022; 10:microorganisms10122420. [PMID: 36557673 PMCID: PMC9782197 DOI: 10.3390/microorganisms10122420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Revised: 11/14/2022] [Accepted: 11/17/2022] [Indexed: 12/12/2022] Open
Abstract
Zika virus (ZIKV), a flavivirus that is mainly transmitted by A. aegypti and A. albopictus and sexual transmission, has been documented and described. The ZIKV RNA detection in the semen of vasectomized men indicates that accessory glands such as the prostate could be a site of virus replication. In this study, we characterized the ZIKV infection, evaluated the antiviral profile, and demonstrated the AXL and TIM-1 expression on the PC3 prostate cell line. It was also determined that PC3 cells are susceptible and permissive to ZIKV infection without altering the cell viability or causing a cytopathic effect. The antiviral profile suggests that the PC3 cells modulate the antiviral response through the suppressor molecule expression, SOCS-1, during a ZIKV infection.
Collapse
|
8
|
Rodríguez-Morales AJ, Bonilla-Aldana DK, Suárez JA, Franco-Paredes C, Forero-Peña DA, Mattar S, Villamil-Gómez WE, Ruíz-Sáenz J, Cardona-Ospina JA, Figuera ME, Sierra-Carrero LL, Risquez A, Cimerman S, Valero-Cedeño N, Cabrera M, Robaina-Barrios AJ, López-Díaz L, Barbella R, Navas RM, Díaz-Quijano F, Carrero Y, Pineda A, Brito MO, Savio-Larriera E, Martinez-Gutierrez M, Maquera-Afaray J, Solarte-Portilla MA, Hernández-Botero S, Contreras K, López MG, Henao-Martinez AF, Ortiz-Martinez Y, Chaves TDSS, Orduna T, Lepetic A, Macchi A, Verbanaz S, Perret C, Echazarreta S, Lloveras SC, Gallego V, Navarro JC, Paniz-Mondolfi A. Yellow fever reemergence in Venezuela - Implications for international travelers and Latin American countries during the COVID-19 pandemic. Travel Med Infect Dis 2021; 44:102192. [PMID: 34751150 PMCID: PMC8553654 DOI: 10.1016/j.tmaid.2021.102192] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2021] [Accepted: 10/26/2021] [Indexed: 11/16/2022]
Affiliation(s)
- Alfonso J Rodríguez-Morales
- Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia; Committe on Tropical Medicine, Zoonoses and Travel Medicine, Colombian Association of Infectious Diseases (ACIN), Bogota, Colombia; Semillero de Zoonosis, Grupo de Investigación GISCA, Fundación Universitaria Autónoma de las Américas, Sede Pereira, Pereira, Risaralda, Colombia; Emerging Infectious Diseases and Tropical Medicine Research Group, Instituto para la Investigación en Ciencias Biomédicas - Sci-Help, Pereira, Risaralda, Colombia; Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Panama City, Panama; Master of Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru; Grupo de Investigación Biomedicina, Faculty of Medicine, Institución Universitaria Visión de las Américas, Pereira, Risaralda, Colombia.
| | - D Katterine Bonilla-Aldana
- Committe on Tropical Medicine, Zoonoses and Travel Medicine, Colombian Association of Infectious Diseases (ACIN), Bogota, Colombia; Semillero de Zoonosis, Grupo de Investigación GISCA, Fundación Universitaria Autónoma de las Américas, Sede Pereira, Pereira, Risaralda, Colombia; Emerging Infectious Diseases and Tropical Medicine Research Group, Instituto para la Investigación en Ciencias Biomédicas - Sci-Help, Pereira, Risaralda, Colombia; Semillero de Zoonosis, Grupo de Investigación GISCA, Institución Universitaria Visión de las Américas, Sede Pereira, Pereira, Risaralda, Colombia
| | - José Antonio Suárez
- Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Panama City, Panama; Investigador SNI Senacyt Panamá, Clinical Research Deparment, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama City, Panama
| | - Carlos Franco-Paredes
- Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Panama City, Panama; Division of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, USA; Hospital Infantil de México, Federico Gómez, México City, Mexico
| | - David A Forero-Peña
- Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolivar, Venezuela
| | - Salim Mattar
- Committe on Tropical Medicine, Zoonoses and Travel Medicine, Colombian Association of Infectious Diseases (ACIN), Bogota, Colombia; Instituto de Investigaciones Biológicas del Trópico, Universidad de Córdoba, Colombia
| | - Wilmer E Villamil-Gómez
- Committe on Tropical Medicine, Zoonoses and Travel Medicine, Colombian Association of Infectious Diseases (ACIN), Bogota, Colombia; Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Panama City, Panama; Infectious Diseases and Infection Control Research Group, Hospital Universitario de Sincelejo, Sincelejo, Sucre, Colombia; Programa del Doctorado de Medicina Tropical, SUE Caribe, Universidad del Atlántico, Barranquilla, Colombia
| | - Julián Ruíz-Sáenz
- Committe on Tropical Medicine, Zoonoses and Travel Medicine, Colombian Association of Infectious Diseases (ACIN), Bogota, Colombia; Grupo de Investigación en Ciencias Animales, Universidad Cooperativa de Colombia, Bucaramanga, Colombia
| | - Jaime A Cardona-Ospina
- Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia; Committe on Tropical Medicine, Zoonoses and Travel Medicine, Colombian Association of Infectious Diseases (ACIN), Bogota, Colombia; Emerging Infectious Diseases and Tropical Medicine Research Group, Instituto para la Investigación en Ciencias Biomédicas - Sci-Help, Pereira, Risaralda, Colombia; Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Panama City, Panama; Semillero de Investigación en Infecciones Emergentes y Medicina Tropical, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia; Grupo de Investigación Biomedicina, Faculty of Medicine, Institución Universitaria Visión de las Américas, Pereira, Risaralda, Colombia
| | | | - Leandro Luis Sierra-Carrero
- Department of Medicine, Health Sciences Division, Universidad del Norte and Hospital Universidad del Norte, Barranquilla, Colombia
| | - Alejandro Risquez
- Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Panama City, Panama; Faculty of Medicine, Universidad Central de Venezuela, Caracas, Venezuela
| | - Sergio Cimerman
- Institute of Infectious Diseases Emilio Ribas, São Paulo, Brazil
| | - Nereida Valero-Cedeño
- Carrera de Laboratorio Clínico, Universidad Estatal del Sur de Manabí, Cantón Jipijapa, Ecuador
| | - Maritza Cabrera
- Vicerrectoría de Investigación y Postgrado (VRIP), Universidad Católica del Maule, Chile
| | - Andrea J Robaina-Barrios
- Cardiology Division, Department of Internal Medicine, Hospital Universitario de Caracas, Faculty of Medicine, Universidad Central de Venezuela, Caracas, Venezuela
| | | | - Rosa Barbella
- Servicio de Anatomía Patológica, Complejo Hospitalario Universitario de Albacete, Facultad de Medicina, Universidad Castilla La Mancha, Albacete, Spain
| | - Rosa M Navas
- Health Care Service, International Airport Camilo Daza, Cúcuta, Norte de Santander, Colombia
| | - Fredi Díaz-Quijano
- Departamento de Epidemiologia, Faculdade de Saúde Pública da Universidade de São Paulo, São Paulo, SP, Brazil
| | | | | | - Maximo O Brito
- Division of Infectious Diseases, Department of Internal Medicine, University of Illinois, Chicago, IL, USA
| | | | - Marlen Martinez-Gutierrez
- Grupo de Investigación en Ciencias Animales-GRICA, Universidad Cooperativa de Colombia, Calle 30A #, 33-51, Bucaramanga, Colombia
| | - Julio Maquera-Afaray
- Infectious Diseases Division, Instituto Nacional de Salud del Niño San Borja, Lima, Peru; Facultad de Ciencias de la Salud, Universidad Privada de Tacna, Tacna, Peru
| | | | - Sebastián Hernández-Botero
- Coordination of Microbiology, School of Medicine, Universidad de Manizales, Manizales, Caldas, Colombia; Grupo de Resistencia Antibiótica de Manizales (GRAM), Manizales, Caldas, Colombia
| | - Krisell Contreras
- Clínica San José, Cúcuta, Norte de Santander, Colombia; Hospital Universitario Erasmo Meoz, Cúcuta, Norte de Santander, Colombia
| | - Maria Graciela López
- Division of Infectious Diseases, Hospital de Niños J. M. de Los Ríos, Caracas, Venezuela; Executive Board, Venezuelan Society of Infectious Diseases, Caracas, Venezuela
| | - Andrés F Henao-Martinez
- Division of Infectious Diseases, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, CO, USA
| | - Yeimer Ortiz-Martinez
- Department of Internal Medicine, Universidad Industrial de Santander, Bucaramanga, Santander, Colombia
| | - Tânia do Socorro Souza Chaves
- Evandro Chagas Institute, Health of Ministry of Brazil, Belém, Pará, Brazil; Faculdade de Medicina da Universidade Federal do Pará, Brazil
| | - Tomas Orduna
- Hospital de Infecciosas F. Muñíz, Buenos Aires, Argentina
| | - Alejandro Lepetic
- Clinical Research & Development and Medical Affairs for GSK Vaccines, Rio de Janeiro, 22783-110, Brazil
| | - Alejandra Macchi
- Hospital de Trauma y Emergencias Federico Abete, Buenos Aires, Argentina
| | | | - Cecilia Perret
- Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile
| | | | - Susana Cristina Lloveras
- Hospital de Infecciosas F. Muñíz, Buenos Aires, Argentina; Universidad de Buenos Aires, Buenos Aires, Argentina
| | - Viviana Gallego
- Panel of Sports and Travel, Latin American Society for Travel Medicine (SLAMVI), Buenos Aires, Argentina
| | - Juan-Carlos Navarro
- Research Group of Emerging Diseases, Ecoepidemiology and Biodiversity, Health Sciences Faculty, Universidad Internacional SEK, Quito, Ecuador; Instituto de Zoología y Ecología Tropical, Facultad de Ciencias, Universidad Central de Venezuela, Caracas, Venezuela
| | - Alberto Paniz-Mondolfi
- Committe on Travel Medicine, Pan-American Association of Infectious Diseases (API), Panama City, Panama; Department of Infectious Diseases and Tropical Medicine, Clínica IDB Cabudare, Instituto de Investigaciones Biomédicas IDB, Barquisimeto, 3023, Lara, Venezuela; Infectious Diseases Research Branch, Venezuelan Science Incubator and the Zoonosis and Emerging Pathogens Regional Collaborative Network, Cabudare, 3023, Lara, Venezuela; Laboratorio de Señalización Celular y Bioquímica de Parásitos, Instituto de Estudios Avanzados (IDEA), Caracas, Caracas, Venezuela; Academia Nacional de Medicina, Caracas, Venezuela; Direction of Microbiology, Department of Pathology, Molecular and Cell-based Medicine, The Mount Sinai Hospital-Icahn School of Medicine at Mount Sinai, New York, USA
| |
Collapse
|
9
|
Loaiza-Cano V, Monsalve-Escudero LM, Restrepo MP, Quintero-Gil DC, Pulido Muñoz SA, Galeano E, Zapata W, Martinez-Gutierrez M. In Vitro and In Silico Anti-Arboviral Activities of Dihalogenated Phenolic Derivates of L-Tyrosine. Molecules 2021; 26:3430. [PMID: 34198817 PMCID: PMC8201234 DOI: 10.3390/molecules26113430] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2021] [Revised: 06/02/2021] [Accepted: 06/02/2021] [Indexed: 12/11/2022] Open
Abstract
Despite the serious public health problem represented by the diseases caused by dengue (DENV), Zika (ZIKV) and chikungunya (CHIKV) viruses, there are still no specific licensed antivirals available for their treatment. Here, we examined the potential anti-arbovirus activity of ten di-halogenated compounds derived from L-tyrosine with modifications in amine and carboxyl groups. The activity of compounds on VERO cell line infection and the possible mechanism of action of the most promising compounds were evaluated. Finally, molecular docking between the compounds and viral and cellular proteins was evaluated in silico with Autodock Vina®, and the molecular dynamic with Gromacs®. Only two compounds (TDC-2M-ME and TDB-2M-ME) inhibited both ZIKV and CHIKV. Within the possible mechanism, in CHIKV, the two compounds decreased the number of genome copies and in the pre-treatment strategy the infectious viral particles. In the ZIKV model, only TDB-2M-ME inhibited the viral protein and demonstrate a virucidal effect. Moreover, in the U937 cell line infected with CHIKV, both compounds inhibited the viral protein and TDB-2M-ME inhibited the viral genome too. Finally, the in silico results showed a favorable binding energy between the compounds and the helicases of both viral models, the NSP3 of CHIKV and cellular proteins DDC and β2 adrenoreceptor.
Collapse
Affiliation(s)
- Vanessa Loaiza-Cano
- Grupo de Investigación en Ciencias Animales-GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga 680005, Colombia; (V.L.-C.); (L.M.M.-E.); (D.C.Q.-G.)
| | - Laura Milena Monsalve-Escudero
- Grupo de Investigación en Ciencias Animales-GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga 680005, Colombia; (V.L.-C.); (L.M.M.-E.); (D.C.Q.-G.)
| | - Manuel Pastrana Restrepo
- Grupo de Investigación en Productos Naturales Marinos, Universidad de Antioquia, Medellín 050001, Colombia; (M.P.R.); (E.G.)
| | - Diana Carolina Quintero-Gil
- Grupo de Investigación en Ciencias Animales-GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga 680005, Colombia; (V.L.-C.); (L.M.M.-E.); (D.C.Q.-G.)
| | | | - Elkin Galeano
- Grupo de Investigación en Productos Naturales Marinos, Universidad de Antioquia, Medellín 050001, Colombia; (M.P.R.); (E.G.)
| | - Wildeman Zapata
- Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellín 050001, Colombia;
| | - Marlen Martinez-Gutierrez
- Grupo de Investigación en Ciencias Animales-GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga 680005, Colombia; (V.L.-C.); (L.M.M.-E.); (D.C.Q.-G.)
| |
Collapse
|
10
|
Sirisena P, Mahilkar S, Sharma C, Jain J, Sunil S. Concurrent dengue infections: Epidemiology & clinical implications. Indian J Med Res 2021; 154:669-679. [PMID: 35532585 PMCID: PMC9210535 DOI: 10.4103/ijmr.ijmr_1219_18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2018] [Indexed: 01/09/2023] Open
Abstract
Multiple dengue virus (DENV) serotypes circulating in a geographical area most often lead to simultaneous infection of two or more serotypes in a single individual. The occurrence of such concurrent infections ranges from 2.5 to 30 per cent, reaching as high as 40-50 per cent in certain dengue hyper-endemic areas. Concurrent dengue manifests itself differently than mono-infected patients, and it becomes even more important to understand the effects of co-infecting serotypes in concurrent infections to ascertain the clinical outcomes of the disease progression and transmission. In addition, there have also been reports of concurrent DENV infections in the presence of other arboviral infections. In this review, we provide a comprehensive breakdown of concurrent dengue infections globally. Furthermore, this review also touches upon the clinical presentations during those concurrent infections categorized as mild or severe forms of disease presentation. Another aspect of this review was aimed at providing insight into the concurrent dengue incidences in the presence of other arboviruses.
Collapse
Affiliation(s)
- P.D.N.N. Sirisena
- ImmunifyMe Healthcare Technologies Pvt. Ltd., Altrade Business Centre, Gurugram, Haryana, India
| | - Shakuntala Mahilkar
- Vector Borne Diseases Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, India
| | - Chetan Sharma
- Vector Borne Diseases Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, India
| | - Jaspreet Jain
- Human Retrovirology Laboratory, Montreal Clinical Research Institute (IRCM), Montreal, Quebec H2W 1R7, Canada
| | - Sujatha Sunil
- Vector Borne Diseases Group, International Centre for Genetic Engineering & Biotechnology, New Delhi, India
| |
Collapse
|